技术资料
-
文献Abdelwahab SF et al. (DEC 2003) Proceedings of the National Academy of Sciences of the United States of America 100 25 15006--10HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
CD4+ T cells are required for immunity against many viral infections,including HIV-1 where a positive correlation has been observed between strong recall responses and low HIV-1 viral loads. Some HIV-1-specific CD4+ T cells are preferentially infected with HIV-1,whereas others escape infection by unknown mechanisms. One possibility is that some CD4+ T cells are protected from infection by the secretion of soluble HIV-suppressive factors,although it is not known whether these factors are produced during primary antigen-specific responses. Here,we show that soluble suppressive factors are produced against CXCR4 and CCR5 isolates of HIV-1 during the primary immune response of human CD4+ T cells. This activity requires antigenic stimulation of naïve CD4+ T cells. One anti-CXCR4 factor is macrophage-derived chemokine (chemokine ligand 22,CCL22),and anti-CCR5 factors include macrophage inflammatory protein-1 alpha (CCL3),macrophage inflammatory protein-1 beta (CCL4),and RANTES (regulated upon activation of normal T cells expressed and secreted) (CCL5). Intracellular staining confirms that CD3+CD4+ T cells are the source of the prototype HIV-1-inhibiting chemokines CCL22 and CCL4. These results show that CD4+ T cells secrete an evolving HIV-1-suppressive activity during the primary immune response and that this activity is comprised primarily of CC chemokines. The data also suggest that production of such factors should be considered in the design of vaccines against HIV-1 and as a mechanism whereby the host can control infections with this virus. View Publication -
文献Jones DC et al. (JUL 2003) Journal of immunology 171 1 196--203Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation.
Expression of the nuclear hormone receptor peroxisome proliferator-activated receptor alpha (PPARalpha) in resting lymphocytes was recently established,although the physiologic role(s) played by this nuclear hormone receptor in these cell types remains unresolved. In this study,we used CD4(+) T cells isolated from PPARalpha(-/-) and wild-type mice,as well as cell lines that constitutively express PPARalpha,in experiments designed to evaluate the role of this hormone receptor in the regulation of T cell function. We report that activated CD4(+) T cells lacking PPARalpha produce increased levels of IFN-gamma,but significantly lower levels of IL-2 when compared with activated wild-type CD4(+) T cells. Furthermore,we demonstrate that PPARalpha regulates the expression of these cytokines by CD4(+) T cells in part,through its ability to negatively regulate the transcription of T-bet. The induction of T-bet expression in CD4(+) T cells was determined to be positively influenced by p38 mitogen-activated protein (MAP) kinase activation,and the presence of unliganded PPARalpha effectively suppressed the phosphorylation of p38 MAP kinase. The activation of PPARalpha with highly specific ligands relaxed its capacity to suppress p38 MAP kinase phosphorylation and promoted T-bet expression. These results demonstrate a novel DNA-binding independent and agonist-controlled regulatory influence by the nuclear hormone receptor PPARalpha. View Publication -
文献Schlecht G et al. (OCT 2001) Journal of immunology (Baltimore,Md. : 1950) 167 8 4215--21Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.
Two distinct dendritic cell (DC) subpopulations have been evidenced in mice on the basis of their differential CD8alpha expression and their localization in lymphoid organs. Several reports suggest that CD8alpha(+) and CD8alpha(-) DC subsets could be functionally different. In this study,using a panel of MHC class I- and/or class II-restricted peptides,we analyzed CD4(+) and CD8(+) T cell responses obtained after i.v. injection of freshly purified peptide-pulsed DC subsets. First,we showed that both DC subsets efficiently induce specific CTL responses and Th1 cytokine production in the absence of CD4(+) T cell priming. Second,we showed that in vivo activation of CD4(+) T cells by CD8alpha(+) or CD8alpha(-) DC,injected i.v.,leads to a nonpolarized Th response with production of both Th1 and Th2 cytokines. The CD8alpha(-) subset induced a higher production of Th2 cytokines such as IL-4 and IL-10 than the CD8alpha(+) subset. However,IL-5 was produced by CD4(+) T cells activated by both DC subsets. When both CD4(+) and CD8(+) T cells were primed by DC injected i.v.,a similar pattern of cytokines was observed,but,under these conditions,Th1 cytokines were mainly produced by CD8(+) T cells,while Th2 cytokines were produced by CD4(+) T cells. Thus,this study clearly shows that CD4(+) T cell responses do not influence the development of specific CD8(+) T cell cytotoxic responses induced either by CD8alpha(+) or CD8alpha(-) DC subsets. View Publication -
文献Griffin DO et al. (JAN 2011) The Journal of experimental medicine 208 1 67--80Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-.
B1 cells differ in many ways from conventional B cells,most prominently in the production of natural immunoglobulin,which is vitally important for protection against pathogens. B1 cells have also been implicated in the pathogenesis of autoimmune dyscrasias and malignant diseases. It has been impossible to accurately study B1 cells during health and illness because the nature of human B1 cells has not been successfully defined. This has produced controversy regarding the existence of human B1 cells. Here,we determined the phenotype of human B1 cells by testing sort-purified B cell fractions for three fundamental B1 cell functions based on mouse studies: spontaneous IgM secretion,efficient T cell stimulation,and tonic intracellular signaling. We found that a small population of CD20(+)CD27(+)CD43(+) cells present in both umbilical cord and adult peripheral blood fulfilled these criteria and expressed a skewed B cell receptor repertoire. These B cells express little or no surface CD69 and CD70,both of which are markedly up-regulated after activation of CD20(+)CD27(-)CD43(-) (naive) and CD20(+)CD27(+)CD43(-) (memory) B cells. This work identifies human B1 cells as CD20(+)CD27(+)CD43(+)CD70(-). We determined that the proportion of B1 cells declines with age,which may contribute to disease susceptibility. Identification of human B1 cells provides a foundation for future studies on the nature and role of these cells in human disease. View Publication -
文献Sauce D et al. (MAY 2011) Blood 117 19 5142--51HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
The mechanisms of CD4(+) T-cell count decline,the hallmark of HIV disease progression,and its relationship to elevated levels of immune activation are not fully understood. Massive depletion of CD4(+) T cells occurs during the course of HIV-1 infection,so that maintenance of adequate CD4(+) T-cell levels probably depends primarily on the capacity to renew depleted lymphocytes,that is,the lymphopoiesis. We performed here a comprehensive study of quantitative and qualitative attributes of CD34(+) hematopoietic progenitor cells directly from the blood of a large set of HIV-infected persons compared with uninfected donors,in particular the elderly. Our analyses underline a marked impairment of primary immune resources with the failure to maintain adequate lymphocyte counts. Systemic immune activation emerges as a major correlate of altered lymphopoiesis,which can be partially reversed with prolonged antiretroviral therapy. Importantly,HIV disease progression despite elite control of HIV replication or virologic success on antiretroviral treatment is associated with persistent damage to the lymphopoietic system or exhaustion of lymphopoiesis. These findings highlight the importance of primary hematopoietic resources in HIV pathogenesis and the response to antiretroviral treatments. View Publication -
文献L. Hang et al. (apr 2019) Journal of immunology (Baltimore,Md. : 1950) 202 8 2473--2481Heligmosomoides polygyrus bakeri Infection Decreases Smad7 Expression in Intestinal CD4+ T Cells, Which Allows TGF-beta to Induce IL-10-Producing Regulatory T Cells That Block Colitis.
Helminthic infections modulate host immunity and may protect their hosts from developing immunological diseases like inflammatory bowel disease. Induction of regulatory T cells (Tregs) may be an important part of this protective process. Heligmosomoides polygyrus bakeri infection also promotes the production of the regulatory cytokines TGF-beta and IL-10 in the gut. In the intestines,TGF-beta helps induce regulatory T cells. This study used Foxp3/IL-10 double reporter mice to investigate the effect of TGF-beta on the differentiation of colon and mesenteric lymph node-derived murine Foxp3- IL-10- CD4+ T cells into their regulatory phenotypes. Foxp3- IL-10- CD4+ T cells from H. polygyrus bakeri-infected mice,as opposed to T cells from uninfected animals,cultured in vitro with TGF-beta and anti-CD3/CD28 mAb differentiated into Foxp3+ and/or IL-10+ T cells. The IL-10-producing T cells nearly all displayed CD25. Smad7 is a natural inhibitor of TGF-beta signaling. In contrast to gut T cells from uninfected mice,Foxp3- IL10- CD4+ T cells from H. polygyrus bakeri-infected mice displayed reduced Smad7 expression and responded to TGF-beta with Smad2/3 phosphorylation. The TGF-beta-induced Tregs that express IL-10 blocked colitis when transferred into the Rag/CD25- CD4+ T cell transfer model of inflammatory bowel disease. TGF-beta had a greatly diminished capacity to induce Tregs in H. polygyrus bakeri-infected transgenic mice with constitutively high T cell-specific Smad7 expression. Thus,infection with H. polygyrus bakeri causes down-modulation in Smad7 expression in intestinal CD4+ T cells,which allows the TGF-beta produced in response to the infection to induce the Tregs that prevent colitis. View Publication
过滤器
筛选结果
研究领域
- HIV 8 项目
- 免疫 35 项目
- 干细胞生物学 8 项目
- 神经科学 1 项目
- 细胞系制备 2 项目
- 药物发现和毒理检测 2 项目
- 癌症研究 1 项目
Show More
Show Less
产品系列
- ClonaCell 2 项目
- EasySep 27 项目
- MethoCult 1 项目
- RoboSep 1 项目
- RosetteSep 5 项目
- StemSpan 4 项目
- TeSR 2 项目
Show More
Show Less
细胞类型
- B 细胞 236 项目
- CD4+ 46 项目
- CD8+ 29 项目
- CHO细胞 19 项目
- HUVEC细胞(人脐静脉内皮细胞) 1 项目
- NK 细胞 174 项目
- PSC衍生 43 项目
- T 细胞 451 项目
- 上皮细胞 126 项目
- 中胚层 5 项目
- 乳腺细胞 102 项目
- 先天性淋巴细胞 41 项目
- 全血 8 项目
- 其他子集 1 项目
- 其他细胞系 9 项目
- 内皮细胞 12 项目
- 内皮集落形成细胞(ECFCs) 3 项目
- 内胚层 3 项目
- 前列腺细胞 19 项目
- 单个核细胞 92 项目
- 单核细胞 191 项目
- 多能干细胞 1986 项目
- 小胶质细胞 4 项目
- 巨噬细胞 43 项目
- 巨核细胞 10 项目
- 心肌细胞 20 项目
- 成骨细胞 9 项目
- 星形胶质细胞 6 项目
- 杂交瘤细胞 97 项目
- 树突状细胞(DCs) 132 项目
- 气道细胞 4 项目
- 淋巴细胞 83 项目
- 癌细胞和细胞系 1 项目
- 白细胞 17 项目
- 白细胞单采样本 12 项目
- 白血病/淋巴瘤细胞 14 项目
- 监管 1 项目
- 真皮细胞 2 项目
- 神经元 2 项目
- 神经干/祖细胞 472 项目
- 神经细胞 16 项目
- 粒细胞及其亚群 106 项目
- 红系细胞 12 项目
- 红细胞 12 项目
- 肌源干/祖细胞 10 项目
- 肝细胞 34 项目
- 肠道细胞 90 项目
- 肾细胞 4 项目
- 肿瘤细胞 25 项目
- 胰腺细胞 16 项目
- 脂肪细胞 6 项目
- 脑肿瘤干细胞 101 项目
- 血小板 4 项目
- 血浆 3 项目
- 血管生成细胞 4 项目
- 调节性细胞 11 项目
- 软骨细胞 8 项目
- 造血干祖细胞 6 项目
- 造血细胞 4 项目
- 间充质基质细胞 20 项目
- 间充质干祖细胞 1 项目
- 间充质细胞 4 项目
- 骨髓基质细胞 1 项目
- 骨髓间质细胞 1 项目
- 髓系细胞 146 项目
- 肾脏细胞 5 项目
- CD4+T细胞 107 项目
- CD8+T细胞 88 项目
- PSC衍生上皮细胞 30 项目
- PSC衍生中胚层 20 项目
- PSC衍生内皮细胞 12 项目
- PSC衍生内胚层 20 项目
- PSC衍生心肌细胞 21 项目
- PSC衍生神经细胞 116 项目
- PSC衍生肝细胞 11 项目
- PSC衍生造血干细胞 25 项目
- PSC衍生间充质细胞 20 项目
- 其他T细胞亚型 24 项目
- 呼吸道细胞 89 项目
- 多巴胺能神经元 6 项目
- 小鼠胚胎成纤维细胞 1 项目
- 浆细胞 12 项目
- 神经元 191 项目
- 调节性T细胞 64 项目
- 骨髓瘤 5 项目
Show More
Show Less

EasySep™小鼠TIL(CD45)正选试剂盒



沪公网安备31010102008431号